Posted by Michael Wonder on 27 Jun 2023
Sun Pharma announces Health Canada approval of Absorica LD (isotretinoin capsules) for treatment of severe nodular acne
26 June 2023 - A new formulation of isotretinoin, the first in over a decade and the only micronised formulation of isotretinoin which provides enhanced bioavailability resulting in comparable rate and extent of isotretinoin exposure with or without food.
Sun Pharma is pleased to announce Health Canada's approval of Absorica LD (isotretinoin capsules).
